KRAS P.G12C
Clinical trials for KRAS P.G12C explained in plain language.
Never miss a new study
Get alerted when new KRAS P.G12C trials appear
Sign up with your email to follow new studies for KRAS P.G12C, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for elderly lung cancer patients: targeted pill shows promise
Disease control OngoingThis study tests a daily pill called adagrasib in 68 patients with a specific type of advanced lung cancer (KRAS G12C mutation) who are either 70 or older or have poor physical health. The goal is to see if the drug can shrink tumors or stop them from growing. Patients take the m…
Matched conditions: KRAS P.G12C
Phase: PHASE2 • Sponsor: ETOP IBCSG Partners Foundation • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Blood samples may unlock secrets of cancer drug resistance
Knowledge-focused OngoingThis study collects blood samples from up to 500 adults in the US with KRAS G12C-positive cancer whose disease has progressed after treatment with a KRAS inhibitor. Researchers will analyze the samples to identify genetic changes that cause resistance. The goal is to compare resi…
Matched conditions: KRAS P.G12C
Sponsor: Addario Lung Cancer Medical Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC